Zola Therapeutics is a biotechnology company advancing the next generation of cancer immunotherapy. Building on decades of innovation in immune stimulatory DNA, Zola’s approach harnesses a synthetic RNA/DNA hybrid designed to mimic the structure of retroviruses, powerfully activating innate immune receptors to drive potent T cell responses against tumors. Named in honor of one of Dr. William Coley’s patients, Zola represents the culmination of a 30-year scientific journey to bring transformative treatments to as many cancer patients as possible.

The visual identity reflects this mission: the logo’s intertwined RNA/DNA forms symbolize the science at Zola’s core, while the bright, energetic colors represent life, hope, and the powerful immune activation the therapy seeks to unleash. The design conveys both the precision of molecular biology and the optimism driving Zola’s vision to change the future of cancer care.